EMT

We investigate how phenotypic plasticity enables cancer cells to leave the primary tumour, survive during dissemination and establish metastatic lesions. Our research focuses particularly on epithelial–mesenchymal transition (EMT) and circulating tumour cells (CTCs) in breast cancer, combining patient-derived material, single-cell molecular profiling and experimental models to understand tumour heterogeneity and identify clinically relevant vulnerabilities.